During the past decade, Axcess Medical Research conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Axcess Medical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Axcess Medical Research" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Axcess Medical Research" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Epilepsy, Partial Seizures" (2 trials), "Migraine" (2 trials), "COVID-19" (1 trials) and "Chronic Migraine in Children" (1 trials). Many other conditions were trialed in "Axcess Medical Research" in a lesser frequency.

Most popular intervention types in "Axcess Medical Research" are "Drug" (13 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Eptinezumab" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "BNT162b2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Axcess Medical Research" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Axcess Medical Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Axcess Medical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Axcess Medical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".